Clinical Trials in the USA / NCT05788757
Active, not recruiting
Observational
Optetrak Knee System Post Market Clinical Follow-Up
NCT05788757 · tracked via the Priya Life Science USA tracker
Condition(s) studied
Knee Arthroplasty, Total
Investigational drug(s) / intervention(s)
Optetrak Total Knee System
Optetrak Total Knee System: Total Knee Arthroplasty using Exactech's Optetrak branded components.
Study summary
A Post-Market Domestic (US) and International Data Collection to Assess the Optetrak Knee System
Eligibility
Inclusion Criteria:
* Patient is indicated for knee replacement, or has already undergone knee replacement, with a device manufactured or distributed by Exactech
* Patient is skeletally mature
* Patient meets the indications detailed in the applicable product package insert Patient is willing and able to review and sign an informed consent form, if necessary
Exclusion Criteria:
* Patient has a local or systemic infection
* Patient has a known sensitivity to one or more of the materials in the knee replacement system to be used
* Patient is pregnant
* Patient has a mental or physical condition that may invalidate evaluation of the data - ---
* Patient is a prisoner
* Surgery is contraindicated according to the applicable product package insert
Primary outcome measure(s)
- Knee Society Score — Preoperative
(KSS) - validated outcome score - Knee Society Score — 6 month postoperative
(KSS) - validated outcome score - Knee Society Score — annually through study completion, maximum of 10-years
(KSS) - validated outcome score - Hospital for Special Surgery Knee Score — Preoperative
(HSS) - validated outcome score - Hospital for Special Surgery Knee Score — 6 month postoperative
(HSS) - validated outcome score - Hospital for Special Surgery Knee Score — annually through study completion, maximum of 10-years
(HSS) - validated outcome score - Oxford Knee Score — Preoperative
(OKS) - validated outcome score - Oxford Knee Score — 6 month postoperative
(OKS) - validated outcome score - Oxford Knee Score — annually through study completion, maximum of 10-years
(OKS) - validated outcome score
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| Fallon Clinic | Worcester | Massachusetts | |
| Nevada Orthopaedic and Spine Center | Las Vegas | Nevada | |
| Medical University South Carolina | Charleston | South Carolina |
More Exactech trials in the USA
Other trials for the same condition
A Post-Market Domestic (US) and International Data Collection to Assess the Truliant Knee System
Recruiting
LEGION Hinge Safety and Efficacy Study
Active, not recruiting
Exactech Knee Systems Post Market Clinical Follow-up
Enrolling by invitation
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05788757 on ClinicalTrials.gov ↗ ← All trials in the USA